Oxidative Stress and Angiogenesis in Primary Hyperparathyroidism

Overview

Journal Eur Surg

Publisher Springer

Specialty General Surgery

Date 2017 Jun 10

PMID 28596785

Citations 7

Authors

Mariusz Deska

Ewa Romuk

Oliwia Anna Segiet

Grzegorz Bula

Witold Truchanowski

Dominika Stolecka

Ewa Birkner

Jacek Gawrychowski

Affiliations

Soon will be listed here.

Abstract

Background: The inappropriate elevation of parathormone (PTH), which regulates the process of angiogenesis in parathyroid tissue, causes the changes of activity of enzymes responsible for the removal of free radicals. Parathyroidectomy (PTX) in patients with primary hyperparathyroidism (PHPT) lowers the level of PTH and leads to the reduction of risk of cardiovascular and all-cause mortality by normalization of the antioxidant status. Therefore, the aims of the study were to assess the activity of antioxidant enzymes and free radical reaction products in patients after parathyroidectomy, and to evaluate the correlation between the systemic oxidative stress and angiogenic parameters.

Materials And Methods: Patients with PHPT treated surgically were enrolled into the study. Total antioxidant capacity (TAC), total oxidative status (TOS), oxidative stress index (OSI), superoxide dismutase (SOD), ceruloplasmin (CER), lipid hydroperoxides (LHP) and malondialdehyde (MDA) were measured before and after parathyroidectomy. The immunohistological expression of angiogenic factors in parathyroid specimens was assessed by the BrightVision method from ImmunoLogic using murine monoclonal anti-human: anti-VEGF, anti-CD31 and anti-CD106 antibodies.

Results: The significant increase of TAC, CER, reduction of TOS, MDA, SOD, especially for cytoplasmic form, and significant decrease of OSI, LHP were observed after PTX. There was no significant correlation between changes of oxidative stress markers and angiogenic parameters: VEGF, CD-31, CD-106 in parathyroid tissue. The correlation level was low and medium.

Conclusions: Parathyroidectomy causes down-regulation of lipid peroxidation processes and leads to reduction of oxidative stress in patients with PHPT. The decrease in the OSI is the results of down-regulation of oxidative stress in the postoperative period. The change of the antioxidant status has no impact on angiogenesis processes in parathyroid tissue.

Citing Articles

The Effect of Dexmedetomidine and Levobupivacaine in an Experimental Ischemia Reperfusion Model.

Ibrahim T, Sevgi K, Sibel O, Surhan C, Kaan K, Kubra B In Vivo. 2024; 38(6):2696-2704.

PMID: 39477431 PMC: 11535938. DOI: 10.21873/invivo.13747.

Meta-Analytical and Meta-Regression Evaluation of Subclinical Hyperthyroidism's Effect on Male Reproductive Health: Hormonal and Seminal Perspectives.

Bahreiny S, Ahangarpour A, Rajaei E, Sharifani M, Aghaei M Reprod Sci. 2024; 31(10):2957-2971.

PMID: 39168918 DOI: 10.1007/s43032-024-01676-8.

Function and mechanism of the human SOD2 gene in mice cerebral ischemia/ reperfusion injury.

Yang X, Wang G Acta Cir Bras. 2024; 39:e393124.

PMID: 39109777 PMC: 11299384. DOI: 10.1590/acb393124.

EFFECT OF PARATHYROIDECTOMY ON OXIDATIVE STRESS IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM.

Abdulrahman S, Kilboz B, Teksoz D, Soylu S, Bolayirli M, Teksoz S Acta Endocrinol (Buchar). 2022; 18(1):20-23.

PMID: 35975258 PMC: 9365408. DOI: 10.4183/aeb.2022.20.

Parathyroid Hormone Causes Endothelial Dysfunction by Inducing Mitochondrial ROS and Specific Oxidative Signal Transduction Modifications.

Gambardella J, De Rosa M, Sorriento D, Prevete N, Fiordelisi A, Ciccarelli M Oxid Med Cell Longev. 2019; 2018:9582319.

PMID: 30662585 PMC: 6313989. DOI: 10.1155/2018/9582319.

References

Kranz A, Mattfeldt T, Waltenberger J . Molecular mediators of tumor angiogenesis: enhanced expression and activation of vascular endothelial growth factor receptor KDR in primary breast cancer. Int J Cancer. 1999; 84(3):293-8. DOI: 10.1002/(sici)1097-0215(19990621)84:3<293::aid-ijc16>3.0.co;2-t. View

Di Leo C, Gallieni M, Bestetti A, Tagliabue L, Cozzolino M, Carpani P . Cardiac and pulmonary calcification in a hemodialysis patient: partial regression 4 years after parathyroidectomy. Clin Nephrol. 2003; 59(1):59-63. DOI: 10.5414/cnp59059. View

Amann K, Tornig J, Flechtenmacher C, Nabokov A, Mall G, Ritz E . Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: evidence for a permissive action of PTH. Nephrol Dial Transplant. 1995; 10(11):2043-8. View

Niki E . Assessment of antioxidant capacity in vitro and in vivo. Free Radic Biol Med. 2010; 49(4):503-15. DOI: 10.1016/j.freeradbiomed.2010.04.016. View

Jiang B, Morimoto S, Yang J, Niinoabu T, Fukuo K, Ogihara T . Expression of parathyroid hormone/parathyroid hormone-related protein receptor in vascular endothelial cells. J Cardiovasc Pharmacol. 1998; 31 Suppl 1:S142-4. DOI: 10.1097/00005344-199800001-00042. View

Rashid G, Bernheim J, Green J, Benchetrit S . Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am J Physiol Renal Physiol. 2006; 292(4):F1215-8. DOI: 10.1152/ajprenal.00406.2006. View

Ogard C, Engelmann M, Kistorp C, Nielsen S, Vestergaard H . Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf). 2005; 63(5):493-8. DOI: 10.1111/j.1365-2265.2005.02363.x. View

Amann K, Ritz E, Wiest G, Klaus G, Mall G . A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol. 1994; 4(10):1814-9. DOI: 10.1681/ASN.V4101814. View

Bevilacqua M . Endothelial-leukocyte adhesion molecules. Annu Rev Immunol. 1993; 11:767-804. DOI: 10.1146/annurev.iy.11.040193.004003. View

10.

Uchida M, Yamato H, Nagai Y, YAMAGIWA H, Hayami T, Tokunaga K . Parathyroid hormone increases the expression level of matrix metalloproteinase-13 in vivo. J Bone Miner Metab. 2001; 19(4):207-12. DOI: 10.1007/s007740170022. View

11.

Erel O . A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem. 2004; 37(4):277-85. DOI: 10.1016/j.clinbiochem.2003.11.015. View

12.

Ybarra J, Donate T, Jurado J, Pou J . Primary hyperparathyroidism, insulin resistance, and cardiovascular disease: a review. Nurs Clin North Am. 2007; 42(1):79-85, vii. DOI: 10.1016/j.cnur.2006.11.010. View

13.

Taki K, Takayama F, Tsuruta Y, Niwa T . Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients. Kidney Int. 2006; 70(1):218-24. DOI: 10.1038/sj.ki.5000330. View

14.

Walgenbach S, Hommel G, Junginger T . Outcome after surgery for primary hyperparathyroidism: ten-year prospective follow-up study. World J Surg. 2000; 24(5):564-9; discussion 569-70. DOI: 10.1007/s002689910092. View

15.

Carter W, Crowell S, Boswell C, Williams S . Stimulation of angiogenesis by canine parathyroid tissue. Surgery. 1996; 120(6):1089-94. DOI: 10.1016/s0039-6060(96)80060-2. View

16.

OLeary D, Wang J, Cotter T, Redmond H . Less stress, more success? Oncological implications of surgery-induced oxidative stress. Gut. 2011; 62(3):461-70. DOI: 10.1136/gutjnl-2011-300948. View

17.

Erel O . A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005; 38(12):1103-11. DOI: 10.1016/j.clinbiochem.2005.08.008. View

18.

Koster J, Biemond P, Swaak A . Intracellular and extracellular sulphydryl levels in rheumatoid arthritis. Ann Rheum Dis. 1986; 45(1):44-6. PMC: 1001813. DOI: 10.1136/ard.45.1.44. View

19.

Brigelius-Flohe R, Maiorino M . Glutathione peroxidases. Biochim Biophys Acta. 2012; 1830(5):3289-303. DOI: 10.1016/j.bbagen.2012.11.020. View

20.

Zhang M, Brewer A, Schroder K, Santos C, Grieve D, Wang M . NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci U S A. 2010; 107(42):18121-6. PMC: 2964252. DOI: 10.1073/pnas.1009700107. View